Overview

Clinical Outcomes From Nalmefene

Status:
Not yet recruiting

Trial end date:
2024-07-26

Target enrollment:

Participant gender:

Summary

The purpose of this study is to assess the effectiveness of nalmefene relative to naloxone for the reversal of opioid intoxication in emergency department (ED) settings.

Phase:

Phase 4

Details

Lead Sponsor:

Purdue Pharma LP

Treatments:

Nalmefene
Naloxone